Lymphoma Trial, Recruiting NCT06608147 Sponsor: Rennes University Hospital Condition: Lymphoma
Back to Lymphoma

Lymphoma Trial, Recruiting

NCT06608147
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are adults (18 years of age or older)
  • People who are admitted to hospital for chest, heart, or blood vessel surgery that involves a procedure where the breastbone is opened (called a sternotomy)
  • People who have given their free, informed, and written agreement to take part
  • People who are covered by a health insurance plan

Who may not be able to join:

  • People who have a history of blood cancer or a known disorder affecting their blood counts
  • People who are currently taking medications that affect the immune system, such as immunosuppressants, steroids, or cancer treatments
  • People who fall under specific categories of protected individuals under French public health law, such as minors or adults under legal protection (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Juliette Ferrant, MD, Rennes University Hospital

Phone: 0299282555

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Rennes University Hospital
Registry
ClinicalTrials.gov
Start date
4 December 2024
Est. completion
1 October 2034

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Flow cytometric quantification of cell populations

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov